1986
DOI: 10.1136/vr.118.17.484
|View full text |Cite
|
Sign up to set email alerts
|

Use of anticonvulsants in small animals

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
6
1

Year Published

1989
1989
2015
2015

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 11 publications
(8 citation statements)
references
References 0 publications
1
6
1
Order By: Relevance
“…However, the severity of the withdrawal syndrome and the number of withdrawal signs markedly increased with longer duration of treatment and higher daily doses, which is consistent with previous observations in rats and baboons (Lukas & Griffiths, 1984;Wilson & Gallager, 1988). Interestingly, after precipitation of withdrawal symptoms by the benzodiazepine antagonist, no additional withdrawal signs were observed on the days after discontinuation of chronic diazepam treatment (after abrupt discontinuation of chronic benzodiazepine treatment in dogs, the withdrawal syndrome is most pronounced after 2-3 days; Scherkl & Frey, 1986), possibly indicating a 're-setting' of benzodiazepine receptors by the antagonist. Plasma level determinations in the dogs suggested that physical dependence on diazepam may have been related to the accumulation and actions of its major metabolite, Ndesmethyldiazepam, because levels of this compound reached during chronic treatment with diazepam were at least 15-20 times higher than those of the parent drug.…”
Section: Discussionsupporting
confidence: 90%
See 1 more Smart Citation
“…However, the severity of the withdrawal syndrome and the number of withdrawal signs markedly increased with longer duration of treatment and higher daily doses, which is consistent with previous observations in rats and baboons (Lukas & Griffiths, 1984;Wilson & Gallager, 1988). Interestingly, after precipitation of withdrawal symptoms by the benzodiazepine antagonist, no additional withdrawal signs were observed on the days after discontinuation of chronic diazepam treatment (after abrupt discontinuation of chronic benzodiazepine treatment in dogs, the withdrawal syndrome is most pronounced after 2-3 days; Scherkl & Frey, 1986), possibly indicating a 're-setting' of benzodiazepine receptors by the antagonist. Plasma level determinations in the dogs suggested that physical dependence on diazepam may have been related to the accumulation and actions of its major metabolite, Ndesmethyldiazepam, because levels of this compound reached during chronic treatment with diazepam were at least 15-20 times higher than those of the parent drug.…”
Section: Discussionsupporting
confidence: 90%
“…As shown in the present study, levels of active benzodiazepines (i.e., diazepam plus active metabolites) after chronic treatment are at least 2 times higher than those determined after a single dose of diazepam. In cats, accumulation of diazepam and desmethyldiazepam is even more pronounced than in dogs, because elimination of these benzodiazepines is much slower in this species (the half-life of diazepam is about 15-20 h in cats compared to 2-5 h in dogs; Frey, 1986). Furthermore, in cats, in contrast to dogs and other species, no tolerance develops during chronic treatment with diazepam (administered at daily doses of 0.5-2mg kg-1, orally for up to several years; Frey, 1986) which could indicate that differences also exist in development of physical dependence between cats and other species.…”
Section: Discussionmentioning
confidence: 99%
“…These results are in contrast with those of previous studies, where the most frequent type of seizures reported were the generalized seizures, 2, [4][5][6][7][8]16,17 apparently without differentiation between primary and secondary generalized seizures. The distribution of seizure types observed in the present study is in accordance with the findings of 3 recent large surveys of seizure types in random groups of human patients.…”
Section: Seizure Typescontrasting
confidence: 56%
“…The half-life varies depending on the duration of PB therapy and prior administration of drugs capable of stimulating drug metabolizing enzyme systems, i.e., enzyme inducers, that would accelerate its d e g r a d a t i~n .~~ Mean half-lives of 52 to 53 hours (range, 37-73 hours) have been reported for mixed-breed dogs receiving chronic oral therapy.5'.s2 The half-life of PB in the cat is 34 to 43 hours. 53 Recommended daily starting dosages are 3 to 5 mg/kg for dogs26,53 and 1 to 3 mg/kg for cats,22 divided q 12 hours. Serum concentrations of 15 to 45 pg/ml are considered therapeutic in dogs.26 Dosage adjustments should be based on trough or postictal serum concentrations.…”
Section: Journal Of Veterinarymentioning
confidence: 99%